Cardinal Health's stock has surged 133% since May 2022, but its long-term chart reveals a history of prolonged correction.

Illustrated on this chart are approved ... to SubQ and equivalent weight loss in those canines. In terms of development, our primary focus is RT-114. As I said, it is a GLP-1/GLP-2 a novel mechanism.

Jim Cramer sees signs of market health, despite doomsday Wall Street whispers. He marvels at how various overlooked ...

The number of people without diabetes taking a GLP-1 drug more than tripled between 2018 and 2022 in the United States, researchers reported Monday in the Annals of Internal Medicine ...

GLP-1 RAs can reduce liver fat, fibrosis progression, and resolve MASH, offering potential benefits for liver health. MASH significantly increases healthcare costs due to comorbidities like ...

JACKSON, WY / ACCESS Newswire / April 1, 2025 / Labor Smart, Inc. (OTC PINK:LTNC), through its newest subsidiary Elevate Health and Wellness Nutritionals, is entering the fast-growing GLP-1 weight ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Studies showed the supplement provides a 22% increase in GLP-1 levels, leading to fewer cravings and glucose spikes. The same data also showed an 11% decrease in insulin resistance. Within three ...

Could a diabetes drug slash your cancer risk? New research shows GLP-1 receptor agonists may protect patients with type 2 diabetes from deadly blood cancers—beyond just managing blood sugar.

The market for GLP-1 medication is estimated by several forecasters to bring in over $100 billion in annual revenue within the next decade. But the drug category, initially developed for diabetes but ...